Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5160 participants.

Also called NCT05182970

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 5,160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05182970
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05182970. Randomized; no masking; primary purpose prevention. Start 2021-12-02 (actual); primary completion 2026-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
Acronym
MIMET
Condition
PreDiabetes
Condition
Acute Myocardial Infarction
Condition
Non ST Elevation Myocardial Infarction
Condition
ST Elevation Myocardial Infarction
Intervention (Drug)
Metformin
Lead sponsor
Karolinska Institutet (class: other)
Collaborator
St Goran's Hospital (class: other)
Collaborator
Uppsala University (class: other)
Collaborator
The Swedish Research Council (class: other government)

Record details

Record id
cardio:ct-nct05182970
Content hash
08878a83014bc35bee00efe1ca9e4634b1209a428c8e703dbd17a0ec4d0d54ae